AstraZeneca PLC (AZNCF)
181.92
0.00 (0.00%)
USD |
OTCM |
Dec 12, 16:00
AstraZeneca EPS Diluted (Quarterly): 1.623 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| GSK Plc | 1.323 |
| Biodexa Pharmaceuticals Plc | -- |
| NuCana Plc | -0.1348 |
| Autolus Therapeutics Plc | -0.2955 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | 2.535B |
| Revenue (Quarterly) | 15.19B |
| Total Expenses (Quarterly) | 12.66B |
| Enterprise Value | 306.56B |
| Gross Profit Margin (Quarterly) | 73.89% |
| Profit Margin (Quarterly) | 16.69% |
| Earnings Yield | 3.31% |
| Operating Earnings Yield | 4.48% |
| Normalized Earnings Yield | 3.380 |